# Shinsei Aoyama Partners

Shinsei Aoyama Partners is an Asset Manager based in Tokyo, Japan.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Tokyo, Japan
- **Region:** Asia
- **Address:** Tokyo, Japan
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** new-lifescience.com
- **LinkedIn:** linkedin.com/company/shinsei-capital-partners

## Regulatory record

- **Reports private funds:** No

## About

新生キャピタルパートナーズ株式会社 is a life science investment firm whose mission is to support the practical application of research from universities, research institutions, and pharmaceutical companies by providing financial backing, helping deliver innovative medicines. The firm operates the New Life Science No. 1 fund and invests in drug-discovery ventures across company-creation, seed, early, middle, and later stages, drawing on experience in finance and pharmaceutical development.

## Sectors

- ライフサイエンス・創薬ベンチャー

## People

- 中村 学（代表取締役）
- 山川 善之（取締役）
- 薦田 貴久（取締役）
- 佐久間 大輔（取締役）
- 小島 冬樹（監査役）

## Questions

### What is Shinsei Aoyama Partners' core investment thesis?

The firm targets succession-driven buyouts of Japanese small-to-mid-cap enterprises. It acquires companies from retiring founders who have no internal successor, then works to professionalize management, upgrade financial controls, and build durable operational infrastructure for long-term stewardship. The thesis is a direct bet on Japan's demographic structure — an aging business-owner class with limited exit options outside of selling to a trusted institutional buyer.

## Related profiles

- [Shijie Huaxia Capital](https://altss.com/profile/shijie-huaxia-capital)
- [Shitao Capital](https://altss.com/profile/shitao-capital)

---

Last updated: 2026-08-11T15:08:04.536Z

Canonical page: https://altss.com/profile/shinsei-aoyama-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology